Trial intelligence / Profile preview

Gentian violet ointment and cryotherapy for cutaneous leishmaniasis

IRCT2017071316557N2Phase 2Completed

Sponsor
Deputy for Research of Shiraz University of Medical Sciences
Start
Oct 2015
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of gentian violet in cutaneous leishmaniasis (CL), sponsored by Deputy for Research of Shiraz University of Medical Sciences. Started Oct 2015; status: completed.

02

Drugs

gentian violet
03

Conditions

cutaneous leishmaniasis (CL)

Beyond the preview

Go deeper on IRCT2017071316557N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017071316557N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call